Your browser doesn't support javascript.
loading
Intranasally administered S-MGB-364 displays antitubercular activity and modulates the host immune response to Mycobacterium tuberculosis infection.
Kieswetter, Nathan S; Ozturk, Mumin; Hlaka, Lerato; Chia, Julius Ebua; Nichol, Ryan J O; Cross, Jasmine M; McGee, Leah M C; Tyson-Hirst, Izaak; Beveridge, Rebecca; Brombacher, Frank; Carter, Katharine C; Suckling, Colin J; Scott, Fraser J; Guler, Reto.
Afiliación
  • Kieswetter NS; International Centre for Genetic Engineering and Biotechnology, Cape Town Component, Cape Town 7925, South Africa.
  • Ozturk M; Department of Pathology, University of Cape Town, Institute of Infectious Diseases and Molecular Medicine (IDM), Division of Immunology and South African Medical Research Council (SAMRC) Immunology of Infectious Diseases, Faculty of Health Sciences, University of Cape Town, Cape Town 7925, South Afr
  • Hlaka L; International Centre for Genetic Engineering and Biotechnology, Cape Town Component, Cape Town 7925, South Africa.
  • Chia JE; Department of Pathology, University of Cape Town, Institute of Infectious Diseases and Molecular Medicine (IDM), Division of Immunology and South African Medical Research Council (SAMRC) Immunology of Infectious Diseases, Faculty of Health Sciences, University of Cape Town, Cape Town 7925, South Afr
  • Nichol RJO; International Centre for Genetic Engineering and Biotechnology, Cape Town Component, Cape Town 7925, South Africa.
  • Cross JM; Department of Pathology, University of Cape Town, Institute of Infectious Diseases and Molecular Medicine (IDM), Division of Immunology and South African Medical Research Council (SAMRC) Immunology of Infectious Diseases, Faculty of Health Sciences, University of Cape Town, Cape Town 7925, South Afr
  • McGee LMC; International Centre for Genetic Engineering and Biotechnology, Cape Town Component, Cape Town 7925, South Africa.
  • Tyson-Hirst I; Department of Pathology, University of Cape Town, Institute of Infectious Diseases and Molecular Medicine (IDM), Division of Immunology and South African Medical Research Council (SAMRC) Immunology of Infectious Diseases, Faculty of Health Sciences, University of Cape Town, Cape Town 7925, South Afr
  • Beveridge R; Department of Pure and Applied Chemistry, University of Strathclyde, Glasgow G1 1XL, Scotland.
  • Brombacher F; Department of Pure and Applied Chemistry, University of Strathclyde, Glasgow G1 1XL, Scotland.
  • Carter KC; Department of Pure and Applied Chemistry, University of Strathclyde, Glasgow G1 1XL, Scotland.
  • Suckling CJ; Department of Pure and Applied Chemistry, University of Strathclyde, Glasgow G1 1XL, Scotland.
  • Scott FJ; Department of Pure and Applied Chemistry, University of Strathclyde, Glasgow G1 1XL, Scotland.
  • Guler R; International Centre for Genetic Engineering and Biotechnology, Cape Town Component, Cape Town 7925, South Africa.
J Antimicrob Chemother ; 77(4): 1061-1071, 2022 03 31.
Article en En | MEDLINE | ID: mdl-35084027
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tuberculosis / Mycobacterium tuberculosis Límite: Animals Idioma: En Revista: J Antimicrob Chemother Año: 2022 Tipo del documento: Article País de afiliación: Sudáfrica
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tuberculosis / Mycobacterium tuberculosis Límite: Animals Idioma: En Revista: J Antimicrob Chemother Año: 2022 Tipo del documento: Article País de afiliación: Sudáfrica